Skip to content
healthcare.dev
Get a free key

SHISEIDO FUTURE solution LX TOTAL PROTECTIVE S

NDC 58411-893, Avobenzone, Homosalate, Octisalate, and Octocrylene, cream, from SHISEIDO AMERICAS CORPORATION.

Product NDC
58411-893
Status
Listed
Labeler
SHISEIDO AMERICAS CORPORATION
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58411-893 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AVOBENZONE1.18565 g/50mL
  • HOMOSALATE5.155 g/50mL
  • OCTISALATE2.31975 g/50mL
  • OCTOCRYLENE2.5775 g/50mL
Package NDCNDC-11Package
58411-893-50584110893501 JAR in 1 CARTON (58411-893-50) / 50 mL in 1 JAR

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58411-893 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58411-893 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58411-893. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.